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OBJECTIVE—We determined whether reduced insulin sensitiv-
ity, mitochondrial dysfunction, and other age-related dysfunc-
tions are inevitable consequences of aging or secondary to
physical inactivity.
RESEARCH DESIGN AND METHODS—Insulin sensitivity
was measured by hyperinsulinemic-euglycemic clamp and ATP
production in mitochondria isolated from vastus lateralis biop-
sies of 42 healthy sedentary and endurance-trained young (18–30
years old) and older (59–76 years old) subjects. Expression of
proteins involved in fuel metabolism was measured by mass
spectrometry. Citrate synthase activity, mitochondrial DNA
(mtDNA) abundance, and expression of nuclear-encoded tran-
scription factors for mitochondrial biogenesis were measured.
SIRT3, a mitochondrial sirtuin linked to lifespan-enhancing ef-
fects of caloric restriction, was measured by immunoblot.
RESULTS—Insulin-induced glucose disposal and suppression of
endogenous glucose production were higher in the trained young
and older subjects, but no age effect was noted. Age-related
decline in mitochondrial oxidative capacity was absent in endur-
ance-trained individuals. Although endurance-trained individuals
exhibited higher expression of mitochondrial proteins, mtDNA,
and mitochondrial transcription factors, there were persisting
effects of age. SIRT3 expression was lower with age in sedentary
but equally elevated regardless of age in endurance-trained
individuals.
CONCLUSIONS—The results demonstrate that reduced insulin
sensitivity is likely related to changes in adiposity and to physical
inactivity rather than being an inevitable consequence of aging.
The results also show that regular endurance exercise partly
normalizes age-related mitochondrial dysfunction, although
there are persisting effects of age on mtDNA abundance and
expression of nuclear transcription factors and mitochondrial
protein. Furthermore, exercise may promote longevity through
pathways common to effects of caloric restriction. Diabetes 57:
2933–2942, 2008
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educed insulin sensitivity is a common factor in
the metabolic syndrome, a cluster of clinical
conditions that shows increased risk with age
(1–3). Mitochondrial dysfunction is also preva-
lent in the elderly (4,5), with reductions in mitochondrial
enzyme activities (6), protein synthesis (7) and expression
(5), and DNA (mtDNA) abundance (5,8). A close associa-
tion between insulin sensitivity and muscle mitochondrial
function has been reported in aging (4,5), type 2 diabetes
(9), and obesity (10) as well as in offspring of type 2
diabetic individuals (11), prompting a hypothesis that
either reduced insulin sensitivity results from muscle
mitochondrial dysfunction (4,11) or vice versa (5,12).
Endurance exercise increases insulin sensitivity (13,14)
and mitochondrial enzyme activities (15,16). Short-term
and longitudinal studies have documented that older pop-
ulations respond favorably to endurance exercise but that
there are persisting age effects that cannot be eliminated
by short-term exercise programs (8,17). For practical
reasons, most training studies are acute interventions,
whereas the effects of aging are chronic. This precludes
conclusions regarding whether older adults are less adapt-
able to exercise training than young adults or if the volume
and duration of the training were insufﬁcient to reveal the
full potential for adaptation. Furthermore, it remains to be
determined whether long-term endurance exercise shares
some of the biochemical effects of caloric restriction,
which prolongs the lifespan of many species through the
DNA-stabilizing actions of sirtuins (18), in particular the
mitochondrial localized SIRT3 (19).
The purpose of this study was to determine if age-
related declines in insulin sensitivity and mitochondrial
function could be prevented by long-term endurance train-
ing. Peripheral and hepatic insulin sensitivity were mea-
sured by euglycemic-hyperinsulinemic clamp in sedentary
and chronically endurance-trained young (18–30 years
old) and older (59–76 years old) subjects. Mitochondrial
function was assessed by measuring muscle ATP produc-
tion rates (MAPR) in isolated mitochondria from vastus
lateralis. To examine molecular and cellular mechanisms
responsible for group differences in mitochondrial func-
tion, citrate synthase (CS) activity, mtDNA, large-scale
protein expression using mass spectrometry, and expres-
sion of key mitochondrial transcription factors, including
nuclear respiratory factor-1 (NRF-1), mitochondrial tran-
scription factor A (TFAM), and their coregulator, peroxi-
somal proliferator–activated receptor  coactivator 1
(PGC-1), were measured. We also determined the effects
of aging on SIRT3 expression and if chronic endurance
training could induce effects similar to caloric restriction
by increasing SIRT3 expression. This study was designed
as a cross-sectional comparison of sedentary and endur-
ance-trained young and old subjects to circumvent the
numerous practical limitations that would complicate a
prospective study of sufﬁcient duration to satisfy the aim
of the study.
RESEARCH DESIGN AND METHODS
A total of 22 healthy young (18–30 years old) and 20 healthy older (59–76
years old) subjects gave written informed consent, as approved by the Mayo
Foundation Institutional Review Board. Subjects were further divided into the
following groups: young sedentary (YS) (5 women, 6 men), young trained (YT)
(5 women, 6 men), older sedentary (OS) (4 women, 6 men), and older trained
(OT) (4 women, 6 men). Sedentary subjects exercised less than 30 min per
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DIABETES, VOL. 57, NOVEMBER 2008 2933day, twice per week. Trained subjects performed at least1ho fcycling or
running 6 days per week over the past 4 years or longer by self-report. Activity
levels were conﬁrmed with a leisure-time activity questionnaire. Subjects
were screened by medical history, physical exam, graded treadmill test, and
comprehensive blood tests, including blood lipids from standard photometric
methods, hormones, and glucose. Magnetic resonance spectroscopy was used
to measure lipoprotein particle concentrations in plasma (20). Brieﬂy, an
EDTA plasma sample diluted 1 to 1 was injected into the ﬂow probe of a
Bruker-Biospin 400-MHz
1H-nuclear magnetic resonance (NMR). Lipana soft-
ware analyzed the data to determine LDL and HDL particle concentration.
Exclusion criteria included history of metabolic or cardiovascular disease,
plasma glucose 99 mg/dl, BMI 28 kg/m
2, medications affecting outcome
measures, anemia, pregnancy, and substance abuse.
Dual X-ray absorptiometry (Lunar DPX-L; Lunar Radiation, Madison, WI)
was used to measure fat and fat-free mass (FFM). Abdominal and visceral fat
area were measured with single-slice computed tomography scans (Imatron
C-150; Imatron, San Francisco, CA), as described previously (21). VO2 peak
was determined from expired gas analysis during a graded bicycle test. To
ensure that subjects achieved VO2 peak, at least two of the following criteria
were conﬁrmed: a plateau in VO2, respiratory exchange ratio 1.1, and
attainment of age-predicted maximal heart rate. At least 7 days after the VO2
peak test, subjects were given a meat-free weight-maintaining diet for 3 days
before inpatient testing and refrained from exercise. At 1700 h on day 3 of the
diet, subjects were admitted to the Mayo Clinic General Clinical Research
Center for 48 h. Muscle mass was estimated from 48-h urinary creatinine
excretion. Subjects were given a standard meal and snack at 1800 and 2200 h
of the second day, after which they remained fasted until the end of the study.
Following baseline blood sampling at 0330 h the following morning, a primed
(2.4 mg/kg FFM), continuous (0.04 mg  kg FFM
1  min
1) infusion of
[6,6-
2H2]-D-glucose was initiated. After 0530 h, one hand was placed in a heated
box (120°F) with a retrograde IV catheter. At 0600 h, arterialized blood
samples were taken every 10 min until 0630 h for [6,6-
2H2]-D-glucose isotopic
enrichment measurements. At 0630 h, a percutaneous needle muscle biopsy
(350–400 mg) was obtained from the vastus lateralis muscle under local
anesthesia (22). Approximately 40 mg of muscle was immediately used for
measurement of MAPR, as previously described (5), and the remaining tissue
was frozen in liquid nitrogen and stored at 80°F for other analyses.
At 0630 h, following the muscle biopsy, an 8-h euglycemic-hyperinsuline-
mic clamp was started with insulin infused at 1.5 mU  kg FFM
1  min
1. The
infusion rate of [6,6-
2H2]-D-glucose was varied to mimic the anticipated
changes in endogenous glucose production, as described previously (23).
Plasma glucose was maintained at 90 mg/dl during insulin infusion with a
variable infusion of 40% dextrose containing 2.15% [6,6-
2H2]-D-glucose to
minimize the changes in glucose enrichments and maintain constant plasma
speciﬁc activity (23). The glucose infusion rate was adjusted as needed based
on blood samples taken at 10-min intervals; samples were measured with a
Beckman glucose analyzer (Beckman Coulter, Fullerton, CA) (24). [6,6-
2H2]-
D-glucose enrichment of blood samples and infusates were measured using
mass spectrometry. As described previously (23), the steady-state equations of
Steele (25) were used to calculate glucose appearance (Ra) and disappearance
(Rd): Ra  Rd  FGlu/SA of [6,6-
2H2] glucose (1), where FGlu is the infusion rate
of [6,6-
2H2]-D-glucose and speciﬁc activity (SA) of [6,6-
2H2] glucose is the
plasma speciﬁc activity of [6,6-
2H2] glucose. Endogenous glucose production
(EGP) was calculated as the difference between total glucose rate of appear-
ance and exogenous glucose infusion rate (23,26). Peripheral insulin sensitiv-
ity was assessed from the rate of glucose infusion required to maintain
euglycemia during the clamp, while hepatic insulin sensitivity was assessed by
the extent to which EGP was suppressed during hyperinsulinemia.
Mitochondrial ATP production. MAPR was measured using a biolumines-
cent technique, as described previously (5). Brieﬂy, 40 mg of fresh muscle
was homogenized and centrifuged to isolate mitochondria. The mitochondria
were suspended in buffer containing 35 mol/l ADP and a luciferin-luciferase
ATP-monitoring reagent (BioThelma, Haninge, Sweden). A BioOrbit 1251
luminometer (BioOrbit Oy, Turku, Finland) was used to monitor biolumines-
cence in response to the addition of glutamate plus malate, palmitoyl-L-
carnitine plus malate, and succinate plus rotenone. All reactions were
monitored for 25 min at 25°C, followed by calibration with an ATP standard.
CS activity was measured using spectrophotometric analyses in the mitochon-
drial pellet (7).
Mitochondrial DNA abundance. DNA were extracted from frozen muscle
samples using a QIAamp DNA mini kit (QIAGEN, Chatworth, CA). The
abundances of mtDNA-encoded NADH dehydrogenase 1 and 4 genes were
measured using a real-time quantitative PCR system (PE Biosystems, Foster
City, CA). Samples were run in duplicate and normalized to S28 ribosomal
DNA, as described previously (5).
Westen blotting. Muscle samples were homogenized in cold lysing buffer
with protease inhibitors. Following centrifugation for 15 min at 1,000g, the
supernatants were diluted to 2 g/l, based on protein concentrations
determined using the Lowry procedure (DC Protein Assay, BioRad). Next,
10-l quantities were loaded and separated on SDS-PAGE (Invitrogen) and
transferred onto polyvinylidene diﬂuouride membranes (BioRad). Membranes
were blocked with Tris-buffered saline with 5% nonfat milk and then washed
with primary antibodies for PGC-1 (516557; Calbiochem, San Diego, CA),
TFAM (PA1–24435; Afﬁnity Bioreagents, Golden, CO), NRF-1 (33771; Santa
Cruz Biotechnology, Santa Cruz, CA), and SIRT3 (ARP32389; Aviva Systems
Biology, San Diego, CA). Following incubation with secondary antibody
conjugated to horseradish peroxidase, membranes were exposed to enhanced
chemiluminescence reagents for 5 min. Densitometric analyses were con-
ducted using a Kodak Image Station 1000.
Proteomics. To determine the abundance of several individual proteins
relevant to cellular ATP production, muscle samples from each subject were
prepared as previously described, and the relative abundance of single
peptides was determined using the iTRAQ approach (27). Samples from YT,
YS, OT, and OS subjects were labeled with iTRAQ reagents 114, 115, 116, and
117, separated, and identiﬁed using liquid chromatography/tandem mass
spectrometry.
Statistical analyses. Data are presented as means  SEM. Two-way (age
and activity level) ANOVA was used to examine the effects of age, activity
level, and the interaction between the two on all outcome variables. When
signiﬁcant interactions were found, post hoc pairwise comparisons were
conducted using Tukey’s procedure. Individual t tests were used for a priori
planned comparisons between OS and YS and between OT and YT. Regression
analyses were conducted to explore the relationships between insulin
sensitivity and predictors such as age, fat mass, activity score, BMI, and
abdominal adiposity. Statistical analyses were conducted using SAS soft-
ware (SAS, Cary, NC).
RESULTS
Subject characteristics. Age was associated with de-
creased muscle mass, increased adiposity, and decreased
VO2 peak (Table 1). In OT and YT subjects, VO2 peak was
higher but percent fat and abdominal and visceral fat
content were lower than in OS and YS subjects. Total and
LDL cholesterol were elevated in OS compared with YS
adults, and HDL cholesterol was elevated in endurance-
trained individuals in both age-groups. Although LDL
cholesterol did not differ between sedentary and endur-
ance-trained individuals, both total and small LDL particle
concentrations measured by NMR were signiﬁcantly lower
in individuals who exercise.
Insulin sensitivity. Average plasma insulin levels during
the clamp were similarly high in YS (44.7  1.9 U/ml), OS
(43.1  3.2 U/ml), YT (45.7  2.1 U/ml), and OT (47.3 
2.3 U/ml) subjects. The glucose infusion rate required to
maintain euglycemia during the clamp was similar in
young and old subjects, but higher in trained compared
with sedentary subjects (Fig. 1A). The area under the
glucose infusion rate curve (Fig. 1A, insets) during 0
through 480 min and 240 through 480 min (plateau region)
indicate greater glucose infusion per unit FFM in trained
compared with sedentary subjects, with no effects of age
in either activity group. Likewise, total Rd during hyperin-
sulinemia was higher in trained compared with sedentary
subjects, with no effects of age (Fig. 1B). EGP was lower
in trained compared with sedentary individuals at baseline
(Fig. 1B). During the clamp, EGP was suppressed in all
groups (YS, 69  7%; YT, 100  11%; OS, 78  7%; and OT,
97  10%), although the magnitude of EGP suppression by
insulin was greater in trained compared with sedentary
subjects (Fig. 1B). No effects of age on EGP or relative
suppression of EGP were noted. The relationship between
Rd and age was nonsigniﬁcant (R  0.11, P  0.53; data not
shown). However, Rd during the clamp was inversely
related to BMI (R  0.37, P  0.026), fat mass (R 
0.53, P  0.001), and abdominal fat (R  0.37, P 
0.027) (data not shown).
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reduced in older versus younger people using substrates
glutamate plus malate, succinate plus rotenone, and pal-
motoyl-L-carnitine plus malate but was higher in endur-
ance-trained compared with sedentary subjects (Page 
0.004) (Fig. 2). Furthermore, paired comparisons revealed
age-related declines in MAPR in sedentary (P  0.006) but
not in trained subjects. Similar results were found for CS
activity (Fig. 3A).
Mitochondrial DNA abundance. The abundance of
mtDNA based on both the NADH dehydrogenase 1 and 4
gene probes was lower in older compared with young
subjects (Page  0.0004, Fig. 3B and C). Although mtDNA
abundance was signiﬁcantly higher in trained compared
with sedentary subjects (Ptraining 	 0.05), mtDNA remained
signiﬁcantly lower in OT compared with YT subjects.
Protein expression of mitochondrial biogenesis
genes. Protein expression of PGC-1, NRF-1, and TFAM
were similar in YS and OS subjects and higher in trained
than in sedentary (Ptraining 	 0.001, Fig. 4) subjects.
PGC-1 and TFAM protein content was signiﬁcantly lower
in OY than in YT subjects (P 	 0.0001); however, NRF-1
expression was similar in YT and OT subjects.
Proteomic data. Figure 5A–D depicts the relative abun-
dance of several proteins involved in key metabolic pro-
cesses in skeletal muscle. Comparison between OS and YS
subjects revealed 27 oxidative and glycolytic proteins with
signiﬁcantly lower relative concentrations in older adults
(Fig. 5A). Endurance-trained young and older individuals
exhibited higher expression of numerous proteins in-
volved in oxidative ATP production relative to their sed-
entary counterparts (Fig. 5B and C). A comparison of YT
and OT subjects revealed that, with the exception of three
subunits of cytochrome c oxidase and an aminotransfer-
ase enzyme, the age differences in protein abundance that
were observed in sedentary individuals were no longer
apparent in endurance-trained individuals (Fig. 5D).
SIRT3 expression. Protein expression of SIRT3 was
lower with age in sedentary adults and signiﬁcantly higher
in trained than in sedentary subjects, with no effect of age
in trained adults (Fig. 6).
DISCUSSION
The current study examined the effects of aging and
endurance exercise on insulin sensitivity and mitochon-
drial function to further explore whether age-related mi-
tochondrial dysfunction and lowering of insulin sensitivity
are inevitable consequences of chronological age. The
main ﬁndings of the present study are, ﬁrst, that YT and OT
subjects had substantially higher insulin sensitivity than
sedentary subjects and that no differences were observed
between young and older subjects in either sedentary or
exercise-trained groups. Second, in contrast, we found
age-related declines in various markers of mitochondrial
function in sedentary groups, but these age-related differ-
ences were partly (but not completely) abolished in people
who practice regular endurance exercise. Finally, we show
that endurance exercise may exert similar potentially
lifespan-enhancing effects to those of caloric restriction
through elevated SIRT3 expression in both young and
older adults.
In agreement with previous reports (4,5), the capacity
for mitochondrial ATP production declined with age in
sedentary adults. As expected, MAPR and CS activity were
higher in endurance-trained than in sedentary individuals.
TABLE 1
Subject characteristics
YS YT OS OT Page Ptraining Pinteraction
n 11 11 10 10
Physical characteristics
Age (years) 22.7  0.7 26.0  1.0 65.1  1.5* 65.4  1.8* 	0.01 0.17 0.26
Height (cm) 172.6  2.7 174.4  2.9 170.8  3.0 167.8  3.0 0.16 0.85 0.41
Weight (kg) 69.4  3.6 69.2  3.8 71.5  4.0 69.1  4.0 0.80 0.73 0.79
BMI (kg/m
2) 23.1  0.9 22.7  0.7 24.4  0.7 24.4  1.0 0.09 0.81 0.75
FFM (kg) 48.5  3.1 53.5  3.0 45.5  3.8 50.4  3.1 0.35 0.14 0.98
Body fat (%) 25.8  1.9 17.4  2.2 32.2  2.9 20.8  3.2 0.06 	0.001 0.55
Muscle mass (kg) 33.7  4.5 33.6  2.3 25.4  2.3* 27.1  1.7 0.02 0.80 0.77
Abdominal fat (cm
2) 185  23 101  20 264  31 186  33* 0.005 0.08 0.57
Visceral fat (cm
2) 59.2  11.0 32.1  4.2 127  16.3* 91.9  19.3* 0.001 0.03 0.98
VO2 peak (ml  kg FFM
1  min
1) 51.2  2.3 66.7  1.7 36.5  1.6* 54.0  3.6* 	0.001 	0.001 0.67
LTA score (min/week) 198  59 990  110 217  77 1,114  206 0.56 	0.001 0.67
Lipids
Total cholesterol (mg/dl) 132  6 135  8 182  9* 167  11* 	0.01 0.45 0.27
HDL cholesterol (mg/dl) 32  24 3  34 7  5* 51  3 	0.01 0.04 0.33
LDL cholesterol (mg/dl) 73  57 8  6 116  9* 97  10 	0.01 0.37 0.13
TG (mg/dl) 134  17 74  7† 98  8* 91  11 — — 0.03
Total HDL particles (mol/l) 30.4  1.3 29.4  1.8 35.3  1.6* 31.9  1.1 0.02 0.12 0.45
Large HDL particles (mol/l) 4.67  0.81 8.25  0.40 6.62  1.27 7.66  0.75 0.42 0.01 0.14
Total LDL particles (nmol/l) 966  79 727  63 1178  74* 1,013  70* 0.001 0.008 0.65
Small LDL particles (nmol/l) 582  112 191  48 487  78 363  79 0.64 0.004 0.11
Glucose and hormones
Glucose (mg/dl) 84.8  1.8 83.2  1.2 89.5  2.0* 92.0  1.7* 	0.01 0.78 0.24
Glucagon (pg/ml) 151  14 142  8 138  6 121  10 0.11 0.23 0.68
Insulin (U/ml) 6.0  0.5 5.0  0.4 5.1  0.5 5.1  2.0 0.70 0.61 0.60
Data are means  SEM unless otherwise indicated. *Unpaired t test indicated values signiﬁcantly (P 	 0.05) different from young subjects
within the same physical activity group; †in the event of a signiﬁcant interaction term, Tukey’s procedure indicated values signiﬁcantly (P 	
0.05) different from untrained subjects within the same age-group. LTA, leisure-time activity questionnaire; TG, triglycerides.
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activity and MAPR in OT compared with YT subjects,
these differences were not statistically signiﬁcant. Thus,
our data underscore the effectiveness of regular endurance
exercise in largely preventing age-related declines in mi-
tochondrial oxidative capacity. Similarly, histochemical
and enzymatic measurements in young (27  3 years old)
and older (63  6 years old) endurance runners showed
that despite 11% lower VO2 peak compared with young
runners, master’s level runners exhibited no signs of
decreased mitochondrial enzyme activities or capillary
density (28). In vitro measures of oxidative capacity, such
as those employed in the present study, provide more
distinct information regarding mitochondrial function than
in vivo measurements of resting mitochondrial ATP pro-
duction, such as those measured using magnetic reso-
nance spectroscopy (4). Given that skeletal muscle is
relatively metabolically inert in the postabsorptive resting
state and that endurance training increases VO2 peak with
minimal effects on resting VO2, it is our belief that the
maximal capacity for mitochondrial ATP synthesis is more
relevant to the study of endurance exercise training and
aging.
Several additional mitochondrial markers were also
assessed in an effort to determine molecular and cellular
mechanisms that would explain our MAPR ﬁndings. Using
mass spectrometry methods, we demonstrated that nu-
merous proteins involved in the citric acid cycle (isocitrate
dehydrogenase, aspartate aminotransferase, malate dehy-
drogenase, and oxoglutarate dehydrogenase) and electron
transport (cytochrome c oxidase, ubiquinol-cytochrome c
reductase, NADH dehydrogenase, and ATP synthase) were
expressed at lower levels in OS compared with YS sub-
jects. Regardless of age, endurance-trained individuals
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FIG. 1. Hyperinsulinemic-euglycemic clamp results. The rates of glu-
cose infusion (GIR) required to maintain euglycemia during the 8-h
clamp were higher in trained compared with sedentary subjects, with
no effects of age (A). Insets show the area under the curve (AUC)
during minutes 240–480, corresponding to a plateau in GIR, and during
the entire clamp (0–480). Rd during hyperinsulinemia was higher in
trained than sedentary subjects (B). No effects of age on Rd were
observed. EGP was suppressed during the clamp in all groups (YS, 69 
7%; YT, 100  11%; OS, 78  7%; and OT, 97  10%). The extent of
suppression did not differ by age, but was greater in trained compared
with sedentary individuals (P  0.01). EGP was not signiﬁcantly
different from zero in trained individuals. Data are presented as
mean  SEM. **Signiﬁcant (P < 0.05) differences in relative suppres-
sion. F, YT; E, OT; Œ, YS; ‚, OS; f, young; , older.
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FIG. 2. Mitochondrial ATP production rates. An age-related decline in
mitochondrial ATP production was observed using substrates gluta-
mate plus malate (GM) (A), succinate plus rotenone (SR) (B), and
palmitoyl-L-carnitine plus malate (PCM) (C) in sedentary subjects.
These effects of age were not apparent in endurance-trained subjects.
Data are presented as means  SEM. *Pairwise comparisons revealed
signiﬁcant (P < 0.05) effects of age within activity groups; **signiﬁ-
cant (P < 0.05) main effects of training. f, young; , older.
ENDURANCE EXERCISE AS A COUNTERMEASURE FOR AGING
2936 DIABETES, VOL. 57, NOVEMBER 2008exhibited higher expression of these proteins. Further-
more, the age-related differences in protein expression
evident in sedentary individuals were absent in endurance-
trained individuals, with the exception of three subunits of
cytochrome c oxidase and aspartate aminotransferase,
which remained signiﬁcantly lower in OT compared with
YT subjects. Our proteomic data closely parallel our
MAPR data, suggesting that the expression level of key
mitochondrial proteins may be a primary determinant of
age-related declines in oxidative capacity and of the
beneﬁcial effects of regular endurance exercise. An impor-
tant point is that regular endurance exercise could not
entirely eliminate the effects of aging on protein expres-
sion, consistent with the 15% lower ATP production
capacity in OT versus YT subjects.
The abundance of mtDNA plays a role in the expression
level of several proteins that were measured using mass
spectrometry: speciﬁcally, subunits of cytochrome c oxidase
and NADH dehydrogenase. Consistent with previous reports
(5,8), we found that mtDNA abundance was signiﬁcantly
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dehydrogenase subunits 1 (ND1) (B) and 4 (ND4) (C) were lower with
age in sedentary and trained subjects. Training was associated with
higher mitochondrial DNA abundance in both age-groups, but the
effects of age remained apparent. Data are presented as means  SEM.
*Pairwise comparisons revealed signiﬁcant (P < 0.05) effects of age
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ance-trained individuals in both age groups exhibited higher
mtDNA abundance. Of interest, the regular endurance exer-
cise did not completely normalize age-related declines in
mtDNA abundance, which we are tempted to posit as a
mechanism explaining persisting age-related deﬁcits in the
protein expression of mitochondrial-encoded cytochrome c
oxidase subunits in endurance-trained individuals.
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FIG. 5. Relative abundance of proteins involved in oxidative and glycolytic ATP production in skeletal muscle. Horizontal bars indicate the
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tochondrial DNA are controlled by TFAM. TFAM expres-
sion is controlled by upstream nuclear transcription
factors (NRF1, NRF2), which also regulate the expression
of nuclear genes encoding mitochondrial proteins. PGC-1
plays a key role in activating these downstream transcrip-
tion factors and, therefore, acts as a control point regulat-
ing mitochondrial biogenesis (29). The protein expression
levels of PGC-1, NRF1, and TFAM were similar in YS and
OS subjects and cannot explain our observations of de-
creased mtDNA abundance in OS subjects. Age-related
accumulation of DNA oxidative damage (5) could explain
reduced mtDNA in OS subjects in spite of similar expres-
sion of mitochondrial transcription factors. PGC-1,
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endurance-trained individuals; however, a key ﬁnding is
that signiﬁcant effects of age were evident for PGC-1 and
TFAM, but not NRF1. Thus, the persisting effects of age on
mtDNA abundance despite endurance exercise training
may be explained by blunted expression of upstream
transcription factors involved in mitochondrial biogenesis.
A key ﬁnding of the current study is related to the effects
of aging and endurance exercise on insulin sensitivity.
Although decreased insulin sensitivity is reported to occur
with age, we found that both hepatic and peripheral
insulin sensitivity were similar in YS and OS subjects.
While the absence of age-related declines in insulin sensi-
tivity is in contrast with numerous previous reports
(4,21,30,31), our results are consistent with a growing
body of literature indicating that adiposity and physical
activity levels, rather than chronological age, are primary
determinants of age-related declines in insulin sensitivity
(32–36). In support of this notion, we ﬁnd that fat mass,
abdominal adiposity, and BMI were signiﬁcant predictors
of Rd during the clamp. The OS subjects in our cohort were
healthy, relatively lean people with substantially less vis-
ceral and abdominal adiposity than what has been re-
ported in older adults with decreased insulin sensitivity
(21). Our ﬁndings are in keeping with earlier studies that
also revealed similarities in insulin sensitivity in relatively
lean sedentary young and older adults (34,37). Peripheral
and hepatic insulin sensitivity were signiﬁcantly higher in
endurance-trained than in sedentary individuals, and these
effects were independent of age. These data are supported
by previous investigators who have demonstrated that
endurance exercise confers substantial improvements in
peripheral and hepatic insulin sensitivity, regardless of age
(14,38,39). The results from the current study strongly
support the notion that decreased insulin sensitivity may
not be an inevitable consequence of aging and that age-
related changes in body composition are a key factor
contributing to the previously reported decline in insulin
sensitivity with aging. Furthermore, in addition to main-
tenance of normal body weight, endurance exercise
should be considered a viable, effective intervention to
reverse, delay, or prevent the onset of age-related
declines in insulin sensitivity that is likely to occur at
more advanced age.
Mitochondrial dysfunction and decreased sensitivity to
insulin are often observed concurrently in type 2 diabetic
(9), elderly (4,5), and obese individuals (10), prompting
two opposing hypotheses concerning this relationship. It
has been proposed that mitochondrial dysfunction plays
an etiological role in the development of insulin resistance
(11,40), while some evidence supports an alternative hy-
pothesis that mitochondrial dysfunction may result from
insulin resistance (41,42). Other studies ﬁnd a dissociation
between mitochondrial capacity and insulin sensitivity
(21,43,44). In the present study, OS subjects were as
insulin sensitive as YS subjects despite signiﬁcantly re-
duced MAPR, casting further doubt on the causal role of
mitochondrial dysfunction in decreasing insulin sensitiv-
ity. However, we observed signiﬁcant elevations in both
oxidative capacity and insulin sensitivity in endurance-
trained individuals regardless of age. These data under-
score the fact that, although mitochondrial function has
been extensively studied in insulin-resistant populations,
our understanding of its role in the development of insulin
resistance is far from complete.
We assessed other outcomes relevant to age-related
comorbidities that may impact insulin sensitivity and
mitochondrial function. Percent body fat, abdominal fat,
and visceral fat were elevated in older adults, and although
these measures were lower in endurance-trained individ-
uals, the effects of age on body composition were not
completely normalized in endurance-trained adults. Simi-
larly, the age-related decline in muscle mass observed in
sedentary individuals was also apparent in endurance-
trained individuals, suggesting that endurance exercise
can partially prevent age-related changes in adiposity but
has limited utility in preventing sarcopenia, which is
prevented by resistance training. Both the traditional
photometric-based clinical lipid panel and NMR-based
method of measuring lipoprotein particle concentrations
revealed the expected elevations of total and LDL choles-
terol in OS compared with YS subjects, as well as the
beneﬁcial increase in HDL cholesterol in both age-groups.
However, while exercise was not related to total LDL
cholesterol when measured photometrically, both total
and small LDL particle concentrations measured by NMR
were signiﬁcantly lower in exercising individuals.
We also provide data to link endurance exercise with
the lifespan-enhancing effects of caloric restriction (45).
Mitochondrial-localized SIRT3 is linked to longevity, pos-
sibly by interfering with the release of apoptosis-inducing
factor (19,46). In a manner similar to that by which
nutrient restriction increases lifespan (19), we found that
SIRT3 expression was higher in endurance-trained than in
sedentary individuals. Furthermore, SIRT3 expression was
lower with age in OS but not OT individuals. Thus, our
results support a hypothesis that exercise may confer
lifespan-extending effects similar to those of caloric re-
striction through the actions of mitochondrial SIRT3.
It is important to consider that many detrimental effects
of old age are compounded after 80 years of age. It is
unclear if similar effects of regular endurance exercise
would be evident in individuals at more advanced ages
than were studied in the present study. It is theoretically
possible that the cross-sectional design of the study may
introduce a sampling bias wherein individuals who exer-
cise across their lifespan do so because their mitochon-
drial function is inherently higher than that of their more
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FIG. 6. Protein expression of SIRT3. Protein expression of SIRT3 was
lower with age in sedentary adults, with no effect of age in trained
adults. Data are presented as means  SEM. *Pairwise comparisons
revealed signiﬁcant (P < 0.05) effects of age within activity groups;
**signiﬁcant (P < 0.05) main effects of training. f, young; , older.
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ingly apparent that waning physical activity levels are a
primary determinant of age-related mitochondrial dysfunc-
tion and may accelerate the aging process through adverse
effects on many biochemical and molecular factors that
require ATP.
In conclusion, we ﬁnd that age-related declines in oxi-
dative capacity can be largely ameliorated by regular
endurance exercise, highlighting the fact that physical
inactivity plays an important role in age-related dysfunc-
tions and underscoring the need for better control of this
variable in the literature. However, certain mitochondrial
markers, speciﬁcally mtDNA, transcription factors, and mi-
tochondrial-encoded proteins, remain depressed with in-
creased age despite endurance exercise. Neither hepatic nor
peripheral insulin sensitivity was impaired with age in these
healthy, relatively lean individuals, which was in keeping
with the notion that adiposity is a primary determinant of
age-related reductions in insulin sensitivity. Notwithstanding,
we illustrate that compared with sedentary individuals,
endurance-trained individuals exhibit elevated insulin sen-
sitivity in a manner independent of age. Finally, we ob-
served an age-related decline in muscle expression of
SIRT3 in sedentary but not endurance-trained individuals,
suggesting that endurance exercise may exert similar
potentially lifespan-enhancing effects to those demon-
strated with caloric restriction in other organisms.
ACKNOWLEDGMENTS
The current study is supported by grants from the National
Institutes of Health (RO1 AG 09531 and UL1 RR024150-01)
and the National Center for Research Resources, training
grant DK07198 from the Mayo Foundation, and the David
Murdock Dole Professorship.
We are grateful for the assistance of the Mayo Clinic
CTSA Clinical Research Unit nursing and nutrition staff,
superior nursing coordination by Maureen Bigelow, and
the skillful technical assistance of Jill Schimke, Lawrence
E. Ward, Dawn Morse, Kate Klaus, and Jane Kahl. Special
thanks are expressed to all of the subjects for their
participation.
REFERENCES
1. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human
disease. Diabetes 37:1595–1607, 1988
2. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C: Deﬁnition
of metabolic syndrome: report of the National Heart, Lung, and Blood
Institute/American Heart Association conference on scientiﬁc issues re-
lated to deﬁnition. Arterioscler Thromb Vasc Biol 24:e13–e18, 2004
3. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome
among US adults: ﬁndings from the third National Health and Nutrition
Examination Survey. J Am Med Assoc 287:356–359, 2002
4. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro
L, Cline GW, Shulman GI: Mitochondrial dysfunction in the elderly:
possible role in insulin resistance. Science 300:1140–1142, 2003
5. Short KR, Bigelow ML, Kahl J, Singh R, Coenen-Schimke J, Raghavakaimal
S, Nair KS: Decline in skeletal muscle mitochondrial function with aging in
humans. Proc Natl Acad Sci 102:5618–5623, 2005
6. Coggan AR, Spina RJ, King DS, Rogers MA, Brown M, Nemeth PM,
Holloszy JO: Histochemical and enzymatic comparison of the gastrocne-
mius muscle of young and elderly men and women. J Gerontol 47:B71–B76,
1992
7. Rooyackers OE, Adey DB, Ades PA, Nair KS: Effect of age on in vivo rates
of mitochondrial protein synthesis in human skeletal muscle. Proc Natl
Acad Sci 93:15364–15369, 1996
8. Menshikova EV, Ritov VB, Fairfull L, Ferrell RE, Kelley DE, Goodpaster
BH: Effects of exercise on mitochondrial content and function in aging
human skeletal muscle. J Gerontol A Biol Sci Med Sci 61:534–540, 2006
9. Kelley DE, He J, Menshikova EV, Ritov VB: Dysfunction of mitochondria in
human skeletal muscle in type 2 diabetes. Diabetes 51:2944–2950, 2002
10. Simoneau JA, Kelley DE: Altered glycolytic and oxidative capacities of
skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol
83:166–171, 1997
11. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI: Impaired
mitochondrial activity in the insulin-resistant offspring of patients with
type 2 diabetes. N Engl J Med 350:664–671, 2004
12. Short KR, Nair KS, Stump CS: Impaired mitochondrial activity and
insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med
350:2419–2421, 2004
13. Cox JH, Cortright RN, Dohm GL, Houmard JA: Effect of aging on response
to exercise training in humans: skeletal muscle GLUT-4 and insulin
sensitivity. J Appl Physiol 86:2019–2025, 1999
14. Seals DR, Hagberg JM, Hurley BF, Ehsani AA, Holloszy JO: Effects of
endurance training on glucose tolerance and plasma lipid levels in older
men and women. J Am Med Assoc 252:645–649, 1984
15. Holloszy JO: Biochemical adaptations in muscle. Effects of exercise on
mitochondrial oxygen uptake and respiratory enzyme activity in skeletal
muscle. J Biol Chem 242:2278–2282, 1967
16. Short KR, Vittone JL, Bigelow ML, Proctor DN, Nair KS: Age and aerobic
exercise training effects on whole body and muscle protein metabolism.
Am J Physiol Endocrinol Metab 286:E92–E101, 2004
17. Hughes VA, Fiatarone MA, Fielding RA, Kahn BB, Ferrara CM, Shepherd P,
Fisher EC, Wolfe RR, Elahi D, Evans WJ: Exercise increases muscle
GLUT-4 levels and insulin action in subjects with impaired glucose
tolerance. Am J Physiol Endocrinol Metab 264:E855–E862, 1993
18. Lamming DW, Wood JG, Sinclair DA: Small molecules that regulate
lifespan: evidence for xenohormesis. Mol Microbiol 53:1003–1009, 2004
19. Yang H, Yang T, Baur JA, Perez E, Matsui T, Carmona JJ, Lamming DW,
Souza-Pinto NC, Bohr VA, Rosenzweig A, de Cabo R, Sauve AA, Sinclair
DA: Nutrient-sensitive mitochondrial NAD
 levels dictate cell survival.
Cell 130:1095–1107, 2007
20. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM: Development of a proton
nuclear magnetic resonance spectroscopic method for determining plasma
lipoprotein concentrations and subspecies distributions from a single,
rapid measurement. Clin Chem 38:1632–1638, 1992
21. Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schimke
JM, Nair KS: Impact of aerobic exercise training on age-related changes in
insulin sensitivity and muscle oxidative capacity. Diabetes 52:1888–1896,
2003
22. Nair KS, Halliday D, Griggs RC: Leucine incorporation into mixed skeletal
muscle protein in humans. Am J Physiol Endocrinol Metab 254:E208–
E213, 1988
23. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD,
Schwenk WF, Rizza RA: Effects of type 2 diabetes on the ability of insulin
and glucose to regulate splanchnic and muscle glucose metabolism:
evidence for a defect in hepatic glucokinase activity. Diabetes 49:272–283,
2000
24. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for
quantifying insulin secretion and resistance. Am J Physiol Endocrinol
Metab 237:E214–E223, 1979
25. Steele R, Wall JS, De Bodo RC, Altszuler N: Measurement of size and
turnover rate of body glucose pool by the isotope dilution method. Am J
Physiol Endocrinol Metab 187:15–24, 1956
26. Finegood DT, Bergman RN, Vranic M: Modeling error and apparent isotope
discrimination confound estimation of endogenous glucose production
during euglycemic glucose clamps. Diabetes 37:1025–1034, 1988
27. Wang XL, Fu A, Raghavakaimal S, Lee HC: Proteomic analysis of vascular
endothelial cells in response to laminar shear stress. Proteomics 7:588–
596, 2007
28. Coggan AR, Spina RJ, Rogers MA, King DS, Brown M, Nemeth PM,
Holloszy JO: Histochemical and enzymatic characteristics of skeletal
muscle in master athletes. J Appl Physiol 68:1896–1901, 1990
29. Finck BN, Kelly DP: PGC-1 coactivators: inducible regulators of energy
metabolism in health and disease. J Clin Invest 116:615–622, 2006
30. DeFronzo RA: Glucose intolerance and aging: evidence for tissue insensi-
tivity to insulin. Diabetes 28:1095–1101, 1979
31. Houmard JA, Weidner MD, Dolan PL, Leggett-Frazier N, Gavigan KE,
Hickey MS, Tyndall GL, Zheng D, Alshami A, Dohm GL: Skeletal muscle
GLUT4 protein concentration and aging in humans. Diabetes 44:555–560,
1995
32. Kohrt WM, Kirwan JP, Staten MA, Bourey RE, King DS, Holloszy JO:
Insulin resistance in aging is related to abdominal obesity. Diabetes
42:273–281, 1993
33. Szoke E, Shrayyef MZ, Messing S, Woerle HJ, van Haeften TW, Meyer C,
Mitrakou A, Pimenta W, Gerich JE: Effect of aging on glucose homeostasis:
I.R. LANZA AND ASSOCIATES
DIABETES, VOL. 57, NOVEMBER 2008 2941accelerated deterioration of beta-cell function in individuals with impaired
glucose tolerance. Diabetes Care 31:539–543, 2008
34. Seals DR, Hagberg JM, Allen WK, Hurley BF, Dalsky GP, Ehsani AA,
Holloszy JO: Glucose tolerance in young and older athletes and sedentary
men. J Appl Physiol 56:1521–1525, 1984
35. O’Shaughnessy IM, Kasdorf GM, Hoffmann RG, Kalkhoff RK: Does aging
intensify the insulin resistance of human obesity? J Clin Endocrinol Metab
74:1075–1081, 1992
36. Basu R, Breda E, Oberg AL, Powell CC, Dalla MC, Basu A, Vittone JL, Klee
GG, Arora P, Jensen MD, Toffolo G, Cobelli C, Rizza RA: Mechanisms of the
age-associated deterioration in glucose tolerance: contribution of alter-
ations in insulin secretion, action, and clearance. Diabetes 52:1738–1748,
2003
37. Broughton DL, James OW, Alberti KG, Taylor R: Peripheral and hepatic
insulin sensitivity in healthy elderly human subjects. Eur J Clin Invest
21:13–21, 1991
38. Kahn SE, Larson VG, Beard JC, Cain KC, Fellingham GW, Schwartz RS,
Veith RC, Stratton JR, Cerqueira MD, Abrass IB: Effect of exercise on
insulin action, glucose tolerance, and insulin secretion in aging. Am J
Physiol Endocrinol Metab 258:E937–E943, 1990
39. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM,
Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with
lifestyle intervention or metformin. N Engl J Med 346:393–403, 2002
40. Lowell BB, Shulman GI: Mitochondrial dysfunction and type 2 diabetes.
Science 307:384–387, 2005
41. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS: Effect of insulin
on human skeletal muscle mitochondrial ATP production, protein synthe-
sis, and mRNA transcripts. Proc Natl Acad Sci 100:7996–8001, 2003
42. Asmann YW, Stump CS, Short KR, Coenen-Schimke JM, Guo Z, Bigelow
ML, Nair KS: Skeletal muscle mitochondrial functions, mitochondrial DNA
copy numbers, and gene transcript proﬁles in type 2 diabetic and nondia-
betic subjects at equal levels of low or high insulin and euglycemia.
Diabetes 55:3309–3319, 2006
43. Toledo FG, Menshikova EV, Azuma K, Radikova Z, Kelley CA, Ritov VB,
Kelley DE: Mitochondrial capacity in skeletal muscle is not stimulated by
weight loss despite increases in insulin action and decreases in intramyo-
cellular lipid content. Diabetes 57:987–994, 2008
44. Nair KS, Bigelow ML, Asmann YW, Chow LS, Coenen-Schimke JM, Klaus
KA, Guo ZK, Sreekumar R, Irving BA: Asian Indians have enhanced skeletal
muscle mitochondrial capacity to produce ATP in association with severe
insulin resistance. Diabetes 57:1166–1175, 2008
45. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz
KT, Gorospe M, de Cabo R, Sinclair DA: Calorie restriction promotes
mammalian cell survival by inducing the SIRT1 deacetylase. Science
305:390–392, 2004
46. Haigis MC, Guarente LP: Mammalian sirtuins–emerging roles in physiol-
ogy, aging, and calorie restriction. Genes Dev 20:2913–2921, 2006
ENDURANCE EXERCISE AS A COUNTERMEASURE FOR AGING
2942 DIABETES, VOL. 57, NOVEMBER 2008